Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Int J Cancer. 2019 Nov 1;146(11):3026–3033. doi: 10.1002/ijc.32713

Table 3.

Oral HPV genotype distribution by country in the HIM study oral subcohort

Brazil (N = 1,198) n (%) Mexico (N = 1,005) n (%) USA (N =895) n (%) p-value1
High-risk HPV types
HPV 16 20 (1.7) 18 (1.8) 14 (1.6)   0.93
HPV 18   8 (0.7)   5 (0.5)   2 (0.2)   0.39
HPV 31   2 (0.2)   4 (0.4)   2 (0.2)   0.61
HPV 33   1 (0.1)   0 (0.0)   4 (0.5)   0.04
HPV 35   1 (0.1)   3 (0.3)   4 (0.5)   0.23
HPV 39   3 (0.3) 15 (1.5)   4 (0.5)   <0.01
HPV 45   2 (0.2)   5 (0.5)   1 (0.1)   0.26
HPV 51   9 (0.8) 15 (1.5)   7 (0.8)   0.16
HPV 52 10 (0.8)   5 (0.5)   7 (0.8)   0.61
HPV 56 10 (0.8)   4 (0.4)   3 (0.3)   0.28
HPV 58   3 (0.3)   3 (0.3)   1 (0.1)   0.80
HPV 59   2 (0.2)   3 (0.3)   2 (0.2)   0.89
HPV 68   0 (0.0)   1 (0.1)   0 (0.0)   0.61
Low-risk HPV types
HPV 6 13 (1.1) 13 (1.3)   4 (0.5)   0.15
HPV 11   2 (0.2)   6 (0.6)   0 (0.0)   0.03
HPV 34   0 (0.0)   0 (0.0)   0 (0.0) n/a 
HPV 40   0 (0.0)   0 (0.0)   0 (0.0) n/a 
HPV 42   0 (0.0)   0 (0.0)   0 (0.0) n/a 
HPV 43   0 (0.0)   0 (0.0)   1 (0.1)   0.29
HPV 44   2 (0.2)   2 (0.2)   1 (0.1)   1.00
HPV 53   9 (0.8)   4 (0.4)   6 (0.7)   0.55
HPV 54   4 (0.3)   0 (0.0)   0 (0.0)   0.04
HPV 66 13 (1.1)   4 (0.4) 10 (1.1)   0.14
HPV 70   0 (0.0)   1 (0.1)   1 (0.1)   0.53
HPV 74   9 (0.8)   5 (0.5)   6 (0.7) 0.76
1

p-values were corrected for multiple comparisons using Benjamini and Hochberg method.